Ben Mead

Ben Mead received his PhD from the University of Birmingham (UK) for work on the use of stem cells to treat retinal disease and to prevent the death of retinal ganglion cells. Currently, he is a post-doctoral fellow at the Section of Retinal Ganglion Cell Biology of the National Eye Institute, Bethesda, MD, USA, where he is investigating the neuroprotective potential of stem cell factors. His current position is funded by the Marie Skłodowska-Curie Fellowship Scheme.